Navigation Links
CID to Update Interventional Cardiologists on Their Drug Eluting Stent Program at TCT 2010
Date:9/16/2010

WASHINGTON, Sept. 16 /PRNewswire/ -- CID s.r.l., a European company leader in interventional medicine, will update interventional cardiologists on the status of their revolutionary drug eluting stent technology during The Drug Eluting Stent (DES) Summit at TCT 2010, Washington, DC on Wednesday, September 22, 2010.  The lecture, entitled "Status of the CID Cre8 polymer-free DES program", will be delivered by Alexandre Abizaid, MD, PhD. Chief of Intervention at Instituto Dante Pazzanese, in Sao Paulo Brazil, and will be part of the session "The Next Generation DES, Polymer-Free".

Some of the highlights of the presentation will include an exploration of the clinical benefits of CID's Abluminal Reservoir Technology (ART) and drug delivery technology. By surrounding molecules of drug with amphiphilic carriers and embedding them into reservoirs on the stent's outer surface, CID drug-eluting stents are able to deliver drug to the coronary arteries without using any polymers, which can cause serious complications in patients.

CID's unique ART system with its amphiphilic carrier is more physiological and patients who receive these stents are less likely to have inflammation and thrombosis within their coronary arteries. Moreover CID DES technology features an integral Bio-Inducer Surface (BIS) which implies less medication to prevent blood clotting after the stent has been deployed for enhanced safety.

Commenting on the innovative technology in its new Cre8 DES, Franco Vallana, Chief Executive Officer of CID s.r.l. said, "We have always known that the more the stent and the drug delivery system are designed and developed to harmonize with the human body, the better the short- and long-term results will be. Combining ART with our innovative drug formulation with amphiphilic carrier into a completely polymer-free stent will allow doctors to provide their patients with stents that are more physiological and complement the body's natural systems."


'/>"/>
SOURCE CID s.r.l.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Vista Partners Updates Coverage on Raptor Pharmaceutical Corp.
2. Encorium Group, Inc. Provides Update on Its Previously Announced Rights Offering
3. Shire Update on ProAmatine(R) (midodrine HCl)
4. Updated Phase 2 Data With Flutemetamol Published in Annals of Neurology
5. Cardiogenesis Executive Chairman Paul J. McCormick Updates Commercial and Regulatory Progress in Interview With Wall Street Reporter, Available Online
6. Cobalis Corp. Provides Marketing Update Conference Call for Investors
7. China Sky One Medical Updates Financial Guidance for 2010
8. Halozyme Provides HYLENEX® Product Reintroduction Update
9. Personalized Medicine: Conference Provides Update on Progress and Prospects
10. UPDATE: China PharmaHub Corp. Introduces a Magic Bullet Liver Cancer Therapy to China, Hong Kong, Taiwan, Macau, Singapore, Malaysia, and Bangladesh
11. Jazz Pharmaceuticals Provides Update on FDA Advisory Committee Meeting For JZP-6 (Sodium Oxybate) in Fibromyalgia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... 2, 2017 Diplomat Pharmacy, Inc. (NYSE: ... and Consulting, LLC , and named its founder as ... in Tennessee , will operate under ... EnvoyHealth,s service offerings for health care partners to include ... "In an interoperable world, technology delivers ...
(Date:9/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... call and webcast on Friday, November 3, 2017, beginning ... ending at approximately 8:30 a.m. (CDT) / 9:30 a.m. ... 2017 financial performance and guidance for 2018, Hill-Rom executives ... enhance operational performance, and long-range financial outlook through 2020. ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., ... vaccine design, and immune-engineering today announced the launch ... the development of personalized therapeutic cancer vaccines. EpiVax ... provided exclusive access to enabling technologies to the ... MBA will lead EpiVax Oncology as Chief Executive ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... for the 49th Congress of the International Society of Paediatric Oncology (SIOP) ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... of Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite ... program on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the ...
(Date:10/12/2017)... ... October 12, 2017 , ... In the United States, ... In some states—like New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, and California—the ... have extremely low property-tax rates, which contributes to the relatively lower cost of ...
(Date:10/12/2017)... D.C. (PRWEB) , ... October 12, 2017 , ... ... Cal Dining at the University of California Berkeley, and other leading institutions in ... the buying power of institutions to change the way animals are raised for ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... manufacturer, has expanded its executive staff with the addition of industry sales leader, ... role, Slott will develop the national distribution and sales network, direct the efforts ...
Breaking Medicine News(10 mins):